A 20 000-person study of eicosapentaenoic acid supplements gave solid scientific support for EPA use to prevent cardiovascular events among patients with established coronary artery disease. Mitsuhiro Yokoyama of Kobe University told us more about it.
[audio:https://www.audiomedica.com/podcasting/aha2005/Mitsuhiro_Yokoyama.mp3]
Direct infusions of HDL to prevent re-infarction in patients with acute coronary syndromes 16 Nov, 2012 
Eight Blood Pressure Genes Bring Promise For Drug Design 29 Jun, 2009 Audio Journal of Cardiovascular Medicine: reporting from American Heart Association Scientific Sessions, Chicago, November 12-15, 2006 18 Nov, 2006 Routine Angioplasty Recommended After Thrombolysis 6 Apr, 2008 
COVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014